Skip to main content
SpringerLink
Log in

Haemochromatosis Arthropathy

  • Chapter
  • First Online:
Gerontorheumatology

  • 707 Accesses

Abstract

Hereditary (primary) haemochromatosis of type I is one of the most frequent autosomal recessive genetic diseases in Europe. Similarly as other types of haemochromatosis, it results from mutation in the gene due to one of the proteins, responsible for regulation of iron metabolism. Although the resulting disorder may be identical, hereditary haemochromatosis must be distinguished from secondary haemochromatosis, i.e. haemosiderosis due to repeated red blood cell transfusions and other rare disorders leading to iron overload (aceruloplasminaemia, atransferrinaemia).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ludwiczek S, Theurl I, Bahram S, Schumann K, Weiss G. Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis. J Cell Physiol. 2005;204(2):489–99.

    Article  CAS  PubMed  Google Scholar 

  2. Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008;7(3):205–14.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Vujic Spasic M, Kiss J, Herrmann T, Galy B, Martinache S, Stolte J, et al. Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab. 2008;7(2):173–8.

    Article  PubMed  Google Scholar 

  4. Vujic Spasic M, Kiss J, Herrmann T, Kessler R, Stolte J, Galy B, et al. Physiologic systemic iron metabolism in mice deficient for duodenal Hfe. Blood. 2007;109(10):4511–7.

    Article  PubMed  Google Scholar 

  5. Ismail MK, Martinez-Hernandez A, Schichman S, Chaudhry S, Waters B. Transplantation of a liver with the C282Y mutation into a recipient heterozygous for H63D results in iron overload. Am J Med Sci. 2009;337(2):138–42.

    Article  PubMed  Google Scholar 

  6. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology. 2009;50(6):1992–2000.

    Article  CAS  PubMed  Google Scholar 

  7. Griffiths WJ. Review article: the genetic basis of haemochromatosis. Aliment Pharmacol Ther. 2007;26(3):331–42.

    Article  CAS  PubMed  Google Scholar 

  8. Zlocha J, Kovács L, Požgayová S, Kupčová V, Durínová S. Molekulárna genetická distnostika a skrínng hereditárnej hemochromatózy. Vnitr Lek. 2006;52(6):602–8 [In Slovak].

    CAS  PubMed  Google Scholar 

  9. Adams PC, Barton JC. Haemochromatosis. Lancet. 2007;370(9602):1855–60.

    Article  CAS  PubMed  Google Scholar 

  10. Crooks CJ, West J, Solaymani-Dodaran M, Card TR. The epidemiology of haemochromatosis: a population-based study. Aliment Pharmacol Ther. 2009;29(2):183–92.

    Article  CAS  PubMed  Google Scholar 

  11. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313(20):1256–62.

    Article  CAS  PubMed  Google Scholar 

  12. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358(3):221–30.

    Article  CAS  PubMed  Google Scholar 

  13. Waalen J, Nordestgaard BG, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol. 2005;18(2):203–20.

    Article  CAS  PubMed  Google Scholar 

  14. Diwakaran HH, Befeler AS, Britton RS, Brunt EM, Bacon BR. Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. J Hepatol. 2002;36(5):687–91.

    Article  CAS  PubMed  Google Scholar 

  15. Gurrin LC, Bertalli NA, Dalton GW, Osborne NJ, Constantine CC, McLaren CE, et al. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology. 2009;50(1):94–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wallace DF, Pedersen P, Dixon JL, Stephenson P, Searle JW, Powell LW, et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood. 2002;100(2):692–4.

    Article  CAS  PubMed  Google Scholar 

  17. Rogowski WH. The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study. Med Decis Making. 2009;29(2):224–38.

    Article  PubMed  Google Scholar 

  18. Elmberg M, Hultcrantz R, Ebrahim F, Olsson S, Lindgren S, Loof L, et al. Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives. Gastroenterology. 2009;137(4):1301–9.

    Article  PubMed  Google Scholar 

  19. Leitman SF. Hemochromatosis: the new blood donor. Hematology Am Soc Hematol Educ Program. 2013;2013:645–50.

    PubMed  Google Scholar 

  20. Schumacher HR, Straka PC, Krikker MA, Dudley AT. The arthropathy of hemochromatosis. Recent studies. Ann N Y Acad Sci. 1988;526:224–33.

    Article  CAS  PubMed  Google Scholar 

  21. Dallos T, Sahinbegovic E, Stamm T, Aigner E, Axmann R, Stadlmayr A, Englbrecht M, Datz C, Schett G, Zwerina J. Idiopathic hand osteoarthritis vs haemochromatosis arthropathy – a clinical, functional and radiographic study. Rheumatology (Oxford). 2013;52(5):910–5.

    Article  CAS  Google Scholar 

  22. Duval H, Lancien G, Marin F, Ropars M, Guggenbuhl P, Chales G. Hip involvement in hereditary hemochromatosis: a clinical-pathologic study. Joint Bone Spine. 2009;76(4):412–5.

    Article  PubMed  Google Scholar 

  23. Carlsson A. Hereditary hemochromatosis: a neglected diagnosis in orthopedics: a series of 7 patients with ankle arthritis, and a review of the literature. Acta Orthop. 2009;80(3):371–4.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Atkins CJ, McIvor J, Smith PM, Hamilton E, Williams R. Chondrocalcinosis and arthropathy: studies in haemochromatosis and in idiopathic chondrocalcinosis. Q J Med. 1970;39(153):71–82.

    CAS  PubMed  Google Scholar 

  25. Valenti L, Fracanzani AL, Rossi V, Rampini C, Pulixi E, Varenna M, Fargion S, Sinigaglia L. The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload. J Rheumatol. 2008;35(1):153–8.

    CAS  PubMed  Google Scholar 

  26. Carroll GJ, Breidahl WH, Bulsara MK, Olynyk JK. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum. 2011;63(1):286–94.

    Article  CAS  PubMed  Google Scholar 

  27. Richette P, Ottaviani S, Vicaut E, Bardin T. Musculoskeletal complications of hereditary hemochromatosis: a case–control study. J Rheumatol. 2010;37(10):2145–50.

    Article  PubMed  Google Scholar 

  28. Heiland GR, Aigner E, Dallos T, Sahinbegovic E, Krenn V, Thaler C, Weiss G, Distler JH, Datz C, Schett G, Zwerina J. Synovial immunopathology in haemochromatosis arthropathy. Ann Rheum Dis. 2010;69(6):1214–9.

    Article  PubMed  Google Scholar 

  29. Muirden KD, Senator GB. Iron in the synovial membrane in rheumatoid arthritis and other joint diseases. Ann Rheum Dis. 1968;27(1):38–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Acton RT, Barton JC, Passmore LV, Adams PC, McLaren GD, Leiendecker-Foster C, Speechley MR, Harris EL, Castro O, Reiss JA, Snively BM, Harrison BW, McLaren CE. Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol. 2008;6(8):934–8.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yazar M, Sarban S, Kocyigit A, Isikan UE. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol Trace Elem Res. 2005;106(2):123–32.

    Article  CAS  PubMed  Google Scholar 

  32. Carroll GJ. Primary osteoarthritis in the ankle joint is associated with finger metacarpophalangeal osteoarthritis and the H63D mutation in the HFE gene: evidence for a hemochromatosis-like polyarticular osteoarthritis phenotype. J Clin Rheumatol. 2006;12(3):109–13.

    Article  PubMed  Google Scholar 

  33. Messer JG, Kilbarger AK, Erikson KM, Kipp DE. Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. Bone. 2009;45(5):972–9.

    Article  CAS  PubMed  Google Scholar 

  34. Carroll GJ, Breidahl WH, Olynyk JK. Characteristics of the arthropathy described in hereditary hemochromatosis. Arthritis Care Res (Hoboken). 2012;64(1):9–14.

    Article  CAS  Google Scholar 

  35. Sanchez M, Galy B, Muckenthaler MU, Hentze MW. Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Nat Struct Mol Biol. 2007;14(5):420–6.

    Article  CAS  PubMed  Google Scholar 

  36. Yang S, Kim J, Ryu JH, Oh H, Chun CH, Kim BJ, Min BH, Chun JS. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med. 2010;16(6):687–93.

    Article  CAS  PubMed  Google Scholar 

  37. Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, Santambrogio P, Arosio P, Ramm GA. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology. 2009;49(3):887–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Latourte A, Frazier A, Brière C, Ea HK, Richette P. Interleukin-1 receptor antagonist in refractory haemochromatosis-related arthritis of the hands. Ann Rheum Dis. 2013;72(5):783–4.

    Article  PubMed  Google Scholar 

  39. Nell-Duxneuner V, Axmann R, Husar-Memmer E, Dallos T, Datz C, Stadlmayr A, Aigner E, Englbrecht M, Schett G, Zwerina J. VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis. Ann Rheum Dis. 2013;72(12):2006–10.

    Article  CAS  PubMed  Google Scholar 

  40. Rovenský J, et al. Hemochromatóza z pohledu reumatológa. Fysiat Vest. 1974;52305(310). [In Slovak].

    Google Scholar 

  41. Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Stölzel U, Keysser G, Datz C, Schett G, Zwerina J. Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum. 2010;62(12):3792–8.

    Article  PubMed  Google Scholar 

  42. Jager HJ, Mehring U, Gotz GF, Neise M, Erlemann R, Kapp HJ, et al. Radiological features of the visceral and skeletal involvement of hemochromatosis. Eur Radiol. 1997;7(8):1199–206.

    Article  CAS  PubMed  Google Scholar 

  43. Dallos T, Sahinbegovic E, Aigner E, Axmann R, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Cavallaro A, Stölzel U, Keysser G, Datz C, Schett G, Manger B, Zwerina J. Validation of a radiographic scoring system for haemochromatosis arthropathy. Ann Rheum Dis. 2010;69(12):2145–51.

    Article  PubMed  Google Scholar 

  44. McDonnell SM, Preston BL, Jewell SA, et al. A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. Am J Med. 1999;106(6):619–24.

    Article  CAS  PubMed  Google Scholar 

  45. Sahinbegovic E, Dallos T, Aigner E, Axmann R, Engelbrecht M, Schöniger-Hekele M, Karonitsch T, Farkas M, Karger T, Willeit J, Stölzel U, Keysser G, Datz C, Kiechl S, Schett G, Zwerina J. Hereditary hemochromatosis as a risk factor for joint replacement surgery. Am J Med. 2010;123(7):659–62.

    Article  PubMed  Google Scholar 

  46. Elmberg M, Hultcrantz R, Simard JF, Carlsson Å, Askling J. Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives. Arthritis Care Res (Hoboken). 2013;65(5):678–85.

    Article  CAS  Google Scholar 

  47. Kennish L, Attur M, Oh C, Krasnokutsky S, Samuels J, Greenberg JD, Huang X, Abramson SB. Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study. BMC Musculoskelet Disord. 2014;15:8.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Wang Y, Gurrin LC, Wluka AE, Bertalli NA, Osborne NJ, Delatycki MB, Giles GG, English DR, Hopper JL, Simpson JA, Graves S, Allen KJ, Cicuttini FM. HFE C282Y homozygosity is associated with an increased risk of total hip replacement for osteoarthritis. Semin Arthritis Rheum. 2012;41(6):872–8.

    Article  CAS  PubMed  Google Scholar 

  49. Barg A, Elsner A, Hefti D, Hintermann B. Total ankle arthroplasty in patients with hereditary hemochromatosis. Clin Orthop Relat Res. 2011;469(5):1427–35.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Department of Paediatrics, Faculty of Medicine, Comenius University in Bratislava, Paediatric University Hospital, Bratislava, Slovakia

    Tomáš Dallos & László Kovács

  2. Medizinische Abteilung, Hanusch Krankenhaus, Ludwig Boltzmann Institut für Osteologie, Wien, Austria

    Jochen Zwerina

Authors
  1. Tomáš Dallos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jochen Zwerina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. László Kovács
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomáš Dallos .

Editor information

Editors and Affiliations

  1. National Institute of Rheumatic Diseases, Piešťany, Slovakia

    Jozef Rovenský

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dallos, T., Zwerina, J., Kovács, L. (2017). Haemochromatosis Arthropathy. In: Rovenský, J. (eds) Gerontorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31169-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31169-2_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31167-8

  • Online ISBN: 978-3-319-31169-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation